QQQ   311.16 (-0.18%)
AAPL   156.41 (+3.71%)
MSFT   264.07 (-0.20%)
META   192.66 (+2.06%)
GOOGL   106.76 (-0.91%)
AMZN   107.96 (-4.38%)
TSLA   198.28 (+5.32%)
NVDA   216.32 (-0.35%)
NIO   11.70 (-2.17%)
BABA   107.45 (-2.09%)
AMD   88.29 (-0.02%)
T   19.91 (-1.82%)
MU   63.39 (+0.35%)
F   13.18 (-7.96%)
CGC   3.06 (-2.55%)
GE   82.99 (-1.13%)
DIS   112.47 (-0.65%)
AMC   6.63 (+9.05%)
PFE   44.10 (-0.54%)
PYPL   86.75 (-0.24%)
NFLX   369.27 (+0.65%)
QQQ   311.16 (-0.18%)
AAPL   156.41 (+3.71%)
MSFT   264.07 (-0.20%)
META   192.66 (+2.06%)
GOOGL   106.76 (-0.91%)
AMZN   107.96 (-4.38%)
TSLA   198.28 (+5.32%)
NVDA   216.32 (-0.35%)
NIO   11.70 (-2.17%)
BABA   107.45 (-2.09%)
AMD   88.29 (-0.02%)
T   19.91 (-1.82%)
MU   63.39 (+0.35%)
F   13.18 (-7.96%)
CGC   3.06 (-2.55%)
GE   82.99 (-1.13%)
DIS   112.47 (-0.65%)
AMC   6.63 (+9.05%)
PFE   44.10 (-0.54%)
PYPL   86.75 (-0.24%)
NFLX   369.27 (+0.65%)
QQQ   311.16 (-0.18%)
AAPL   156.41 (+3.71%)
MSFT   264.07 (-0.20%)
META   192.66 (+2.06%)
GOOGL   106.76 (-0.91%)
AMZN   107.96 (-4.38%)
TSLA   198.28 (+5.32%)
NVDA   216.32 (-0.35%)
NIO   11.70 (-2.17%)
BABA   107.45 (-2.09%)
AMD   88.29 (-0.02%)
T   19.91 (-1.82%)
MU   63.39 (+0.35%)
F   13.18 (-7.96%)
CGC   3.06 (-2.55%)
GE   82.99 (-1.13%)
DIS   112.47 (-0.65%)
AMC   6.63 (+9.05%)
PFE   44.10 (-0.54%)
PYPL   86.75 (-0.24%)
NFLX   369.27 (+0.65%)
QQQ   311.16 (-0.18%)
AAPL   156.41 (+3.71%)
MSFT   264.07 (-0.20%)
META   192.66 (+2.06%)
GOOGL   106.76 (-0.91%)
AMZN   107.96 (-4.38%)
TSLA   198.28 (+5.32%)
NVDA   216.32 (-0.35%)
NIO   11.70 (-2.17%)
BABA   107.45 (-2.09%)
AMD   88.29 (-0.02%)
T   19.91 (-1.82%)
MU   63.39 (+0.35%)
F   13.18 (-7.96%)
CGC   3.06 (-2.55%)
GE   82.99 (-1.13%)
DIS   112.47 (-0.65%)
AMC   6.63 (+9.05%)
PFE   44.10 (-0.54%)
PYPL   86.75 (-0.24%)
NFLX   369.27 (+0.65%)
NASDAQ:SGEN

Seagen - SGEN Stock Forecast, Price & News

$138.16
-1.27 (-0.91%)
(As of 02/3/2023 10:46 AM ET)
Add
Compare
Today's Range
$137.50
$139.68
50-Day Range
$117.37
$140.67
52-Week Range
$105.43
$183.00
Volume
86,308 shs
Average Volume
940,809 shs
Market Capitalization
$25.65 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$161.21

Seagen MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
16.8% Upside
$161.21 Price Target
Short Interest
Healthy
1.62% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.96
Upright™ Environmental Score
News Sentiment
0.08mentions of Seagen in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$7.28 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.53) to ($2.30) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Medical Sector

454th out of 1,029 stocks

Biological Products, Except Diagnostic Industry

75th out of 169 stocks

SGEN stock logo

About Seagen (NASDAQ:SGEN) Stock

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997, and is headquartered in Bothell, WA.

Receive SGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter.

SGEN Stock News Headlines

Seagen Inc. (NASDAQ:SGEN) CMO Roger D. Dansey Sells 10,000 Shares
Seagen Inc. (NASDAQ:SGEN) Insider Jean I. Liu Sells 5,000 Shares
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
Morgan Stanley Cuts Seagen (NASDAQ:SGEN) Price Target to $170.00
Seagen (NASDAQ:SGEN) PT Lowered to $170.00 at Berenberg Bank
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
Seagen Reports Third Quarter 2022 Financial Results
A Bearish Sign Appears On Seagen's Chart
See More Headlines
Receive SGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter.

SGEN Company Calendar

Last Earnings
10/28/2021
Today
2/03/2023
Next Earnings (Confirmed)
2/15/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:SGEN
CUSIP
81257810
Employees
2,675
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$161.21
High Stock Price Forecast
$188.00
Low Stock Price Forecast
$135.00
Forecasted Upside/Downside
+16.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
16 Analysts

Profitability

Net Income
$-674,470,000.00
Pretax Margin
-34.09%

Debt

Sales & Book Value

Annual Sales
$1.57 billion
Book Value
$16.76 per share

Miscellaneous

Free Float
134,978,000
Market Cap
$25.65 billion
Optionable
Optionable
Beta
0.58

Social Links


Key Executives

  • David R. Epstein
    Chief Executive Officer & Director
  • Todd E. SimpsonTodd E. Simpson
    Chief Financial Officer
  • Vaughn B. HimesVaughn B. Himes
    Chief Technical Officer
  • Roger D. DanseyRoger D. Dansey
    Chief Medical Officer
  • Natasha A. Hernday
    Executive Vice President-Corporate Development













SGEN Stock - Frequently Asked Questions

Should I buy or sell Seagen stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Seagen in the last twelve months. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SGEN shares.
View SGEN analyst ratings
or view top-rated stocks.

What is Seagen's stock price forecast for 2023?

16 equities research analysts have issued 12 month target prices for Seagen's stock. Their SGEN share price forecasts range from $135.00 to $188.00. On average, they predict the company's share price to reach $161.21 in the next twelve months. This suggests a possible upside of 15.6% from the stock's current price.
View analysts price targets for SGEN
or view top-rated stocks among Wall Street analysts.

How have SGEN shares performed in 2023?

Seagen's stock was trading at $128.51 at the beginning of the year. Since then, SGEN shares have increased by 8.5% and is now trading at $139.43.
View the best growth stocks for 2023 here
.

Are investors shorting Seagen?

Seagen saw a increase in short interest in January. As of January 15th, there was short interest totaling 3,000,000 shares, an increase of 15.4% from the December 31st total of 2,600,000 shares. Based on an average daily volume of 982,200 shares, the days-to-cover ratio is currently 3.1 days.
View Seagen's Short Interest
.

When is Seagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our SGEN earnings forecast
.

How can I listen to Seagen's earnings call?

Seagen will be holding an earnings conference call on Wednesday, February 15th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Seagen's earnings last quarter?

Seagen Inc. (NASDAQ:SGEN) released its earnings results on Thursday, October, 28th. The biotechnology company reported ($1.61) earnings per share for the quarter, missing the consensus estimate of ($0.56) by $1.05. The biotechnology company had revenue of $424.60 million for the quarter, compared to the consensus estimate of $384.83 million. Seagen had a negative trailing twelve-month return on equity of 21.56% and a negative net margin of 34.16%. Seagen's revenue for the quarter was down 60.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.50 earnings per share.

What is Clay B. Siegall's approval rating as Seagen's CEO?

107 employees have rated Seagen Chief Executive Officer Clay B. Siegall on Glassdoor.com. Clay B. Siegall has an approval rating of 99% among the company's employees. This puts Clay B. Siegall in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Seagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Seagen investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Salesforce (CRM), QUALCOMM (QCOM), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Alibaba Group (BABA).

What is Seagen's stock symbol?

Seagen trades on the NASDAQ under the ticker symbol "SGEN."

Who are Seagen's major shareholders?

Seagen's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.24%), Manning & Napier Group LLC (0.19%), Pinnacle Associates Ltd. (0.13%), Pinnacle Associates Ltd. (0.13%), National Bank of Canada FI (0.10%) and DekaBank Deutsche Girozentrale (0.09%). Insiders that own company stock include Bros Advisors Lp Baker, Charles R Romp, Charles R Romp, Clay B Siegall, Clay B Siegall, Daniel G Welch, Daniel G Welch, David W Gryska, David W Gryska, Jean I Liu, Jean I Liu, Marc E Lippman, Morgan E Obrien, Roger D Dansey, Roger D Dansey, Todd E Simpson, Todd E Simpson, Vaughn B Himes and Vaughn B Himes.
View institutional ownership trends
.

How do I buy shares of Seagen?

Shares of SGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Seagen's stock price today?

One share of SGEN stock can currently be purchased for approximately $139.43.

How much money does Seagen make?

Seagen (NASDAQ:SGEN) has a market capitalization of $25.89 billion and generates $1.57 billion in revenue each year. The biotechnology company earns $-674,470,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis.

How many employees does Seagen have?

The company employs 2,675 workers across the globe.

Does Seagen have any subsidiaries?
The following companies are subsidiares of Seagen: Cascadian Therapeutics.
Read More
How can I contact Seagen?

Seagen's mailing address is 21823 30TH DRIVE SE SUITE, BOTHELL WA, 98021. The official website for the company is www.seattlegenetics.com. The biotechnology company can be reached via phone at (425) 527-4000, via email at investors@seagen.com, or via fax at 425-527-4001.

This page (NASDAQ:SGEN) was last updated on 2/3/2023 by MarketBeat.com Staff